Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Tick-borne encephalitis in mainland China.
It is shown that foci of the virus are mostly located in the northern part of China and that surveillance on TBE is not institutionalized, and data are incomplete and not appropriately communicated.
New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad.
Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe.
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.
Meningococcal serogroup Y emergence in Europe
- M. Bröker, S. Jacobsson, G. Tzanakaki
- Medicine, BiologyHuman vaccines & immunotherapeutics
- 2 October 2012
Data is reported indicating that the emergence of serogroup Y continued in 2011 in various regions of Europe, and the average age of persons affected by N. meningitidis serogroups Y seems to have decreased in some countries in comparison to the previous decade.
Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas.
Serum bactericidal antibody assays - The role of complement in infection and immunity.
Safety of MDCK cell culture-based influenza vaccines.
An overview of the safety profile of the cell culture technology, of the cells and of the final vaccine product is provided.
Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013
Additional data from 30 European countries are reported indicating that high or increased serogroup Y disease levels have continued in 2013 in certain regions of Europe, and the age distribution of serogroups Y was bimodal and did not change significantly despite the increase of the total number and the proportion of serogsroup Y IMD in some European regions.